Table 3.
Diabetes complications
| T2DM without LGE | T2DM with ischemic LGEa | T2DM with non-ischemic LGE | P-valueb | P-valuec | |
|---|---|---|---|---|---|
| Albuminuria (%) | 72 (35) | 17 (55) | 8 (32) | 0.09 | – |
| Retinopathy (%) | 51 (25) | 8 (28) | 12 (48) | 0.054 | 0.009 |
| Autonomic neuropathy (%) | 62 (30.5) | 14 (47) | 13 (52) | 0.03 | 0.005 |
| Peripheral neuropathy (%) | 78 (40) | 15 (52) | 12 (50) | 0.34 | – |
| Beat-to-beat variation (bpm) | 11.1 IQR6.8–17.8 | 7.3 IQR3.4–11.9 | 6.5 IQR3.9–11.0 | 0.0003 | 0.0029 |
| Beat-to-beat ≤ 6 (%) | 55 (27) | 14 (44) | 12 (50) | 0.01 | 0.02 |
| Orthostatic blood pressure fall (mmHg) | 12.0 IQR5–18 | 11.5 IQR4–19.5 | 13.0 IQR5–21 | 0.34 | – |
| Orthostatic blood pressure fall ≥ 25 (%) | 27 (13) | 6 (19) | 3 (12) | 0.66 | – |
Data presented as median and interquartile range (IQR) or as nominal values with percentages in parentheses
aIncluding three patients with both ischemic and non-ischemic lesions
bComparison between all three groups as appropriate
cComparison between T2DM patients with non-ischemic LGE vs. T2DM patients without LGE